[1] Xiao J, Wang F, Wong NK, et al. Global liver disease burdens and research trends: Analysis from a Chinese perspective. J Hepatol, 2019, 71(1):212-221. [2] D'Amico G. The clinical course of cirrhosis. Population based studies and the need of personalized medicine. J Hepatol, 2014, 60(2):241-242. [3] Walter CJ, Bell LT, Parsons SR, et al. Prevalence and significance of anaemia in patients receiving long-course neoadjuvant chemoradiotherapy for rectal carcinoma. Colorectal Dis, 2013, 15(1):52-56. [4] Zhang YH, Lu Y, Lu H, et al. Pre-treatment hemoglobin levels are an independent prognostic factor in patients with non-small cell lung cancer. Mol Clin Oncol, 2018, 9(1):44-49. [5] Maino A, Abbattista M, Bucciarelli P, et al. Red cell distribution width and the risk of cerebral vein thrombosis: A case-control study. Eur J Intern Med, 2017, 38:46-51. [6] Ahmad H, Khan M, Laugle M, et al. Red cell distribution width is positively correlated with atherosclerotic cardiovascular disease 10-year risk score, age, and CRP in spondyloarthritis with axial or peripheral disease. Int J Rheumatol, 2018, 2018:2476239. [7] Ozgul G, Seyhan EC, Özgül MA, Günlüogˇlu MZ. Red Blood Cell Distribution Width in Patients With Chronic Obstructive Pulmonary Disease and Healthy Subjects. Arch Bronconeumol, 2017, 53(3):107-113. [8] Bello S, Fandos S, Lasierra AB, et al. Red blood cell distribution width [ RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin. Respir Med, 2015, 109(9):1193-1206. [9] European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol, 2018, 69(2):406-460. [10] Scheiner B, Semmler G, Maurer F, et al. Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease. Liver Int, 2020, 40(1):194-204. [11] Clevenger B, Mallett SV. Transfusion and coagulation management in liver transplantation. World J Gastroenterol, 2014, 20(20):6146-6158. [12] Güngör G, Akyıldız M, Keskin M, et al. Is there any potential or additive effect of anemia on hepatorenal syndrome?. Turk J Gastroenterol, 2016, 27(3):273-278. [13] Cai M, Yang N, Lin S, et al. Anemia predicts poor outcomes in patients with HBV-related decompensated cirrhosis. Clin Lab, 2021, 67(3):10.7754/Clin.Lab.2020.200701. [14] Salvagno GL, Sanchis-Gomar F, Picanza A, et al. Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci, 2015, 52(2):86-105. [15] Lou Y, Wang M, Mao W. Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PLoS One, 2012, 7(5):e37644. [16] Turcato G, Campagnaro T, Bonora A, et al. Red blood cell distribution width independently predicts 1-month mortality in acute decompensation of cirrhotic patients admitted to emergency department. Eur J Gastroenterol Hepatol, 2018, 30(1):33-38. [17] Behroozian R, Bayazidchi M, Rasooli J. Systemic inflammatory response syndrome and MELD score in hospital outcome of patients with liver cirrhosis. Middle East J Dig Dis, 2012, 4(3):168-172. [18] Groarke EM, Young NS. Aging and hematopoiesis. Clin Geriatr Med, 2019, 35(3):285-293. [19] Kozlitina J, Garcia CK. Red blood cell size is inversely associated with leukocyte telomere length in a large multi-ethnic population. PLoS One, 2012, 7(12):e51046. |